Does RUXOLITINIB Cause Hypoglycaemia? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Hypoglycaemia have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.1% of all adverse event reports for RUXOLITINIB.
44
Reports of Hypoglycaemia with RUXOLITINIB
0.1%
of all RUXOLITINIB reports
13
Deaths
28
Hospitalizations
How Dangerous Is Hypoglycaemia From RUXOLITINIB?
Of the 44 reports, 13 (29.5%) resulted in death, 28 (63.6%) required hospitalization, and 10 (22.7%) were considered life-threatening.
Is Hypoglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Hypoglycaemia?
METFORMIN (5,047)
INSULIN GLARGINE (4,212)
INSULIN LISPRO (2,141)
INSULIN ASPART (1,647)
GLIMEPIRIDE (1,403)
INSULIN HUMAN (1,350)
INSULIN DEGLUDEC (762)
GLICLAZIDE (756)
ACETAMINOPHEN (684)
SITAGLIPTIN (674)
Which RUXOLITINIB Alternatives Have Lower Hypoglycaemia Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE